Literature DB >> 466215

Hyperparathyroidism--a reversible cause of cimetidine-resistant gastric hypersecretion.

D M McCarthy, S R Peikin, R N Lopatin, B W Long, A Spiegel, S Marx, M Brennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 466215      PMCID： PMC1599377          DOI： 10.1136/bmj.1.6180.1765

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy.

Authors:  D M McCarthy; E J Olinger; R J May; B W Long; J D Gardner
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

2.  Report on the United States experience with cimetidine in Zollinger-Ellision syndrome and other hypersecretory states.

Authors:  D M McCarthy
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682
  2 in total
  8 in total

Review 1.  Gastrinomas: Medical or Surgical Treatment.

Authors:  Jeffrey A Norton; Deshka S Foster; Tetsuhide Ito; Robert T Jensen
Journal:  Endocrinol Metab Clin North Am       Date:  2018-09       Impact factor: 4.741

2.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

3.  The role of surgery in patients with Zollinger-Ellison syndrome (ZES) managed medically.

Authors:  M F Brennan; R T Jensen; R A Wesley; J L Doppman; D M McCarthy
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

4.  Failure of cimetidine to suppress immunoreactive parathyroid hormone and hypercalcaemia in primary hyperparathyroidism.

Authors:  R B Mallett; R Sainsbury; K G Benton
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

5.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

6.  Current management of Zollinger-Ellison syndrome.

Authors:  R T Jensen; P N Maton; J D Gardner
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 7.  Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

Authors:  D C Metz; J R Pisegna; V A Fishbeyn; R V Benya; R T Jensen
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

8.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.